portfolio
medical health
eloxx pharmaceuticals
founded in 2013, eloxx pharmaceuticals is a biopharmaceutical company committed to treating patients suffering from rare and ultra-rare genetic diseases caused by premature termination codons nonsense mutation. the company is focused on the discovery, development and commercialization of compounds for the treatment of genetic diseases, such as cystic fibrosis and cystinosis.
amcare women's and children's hospital
established in 2004, amcare women's & children's hospital (amcare) is committed to providing premium services in gynecology, obstetrics and pediatrics. by introducing the advanced healthcare service management system and combining the domestic and overseas core technologies, amcare aims to become the high end medical service provider in china.
betta pharma
betta pharmaceuticals co., ltd., founded by overseas returnee doctors in 2003, is recognized as a full-capacity pharmaceutical company in china and a modern high-tech enterprise. at betta pharma, innovation has penetrated into our daily activities and become an inclusive culture. our portfolio of products and pipeline of investigational drugs include treatments for cancer, cardiovascular disease and metabolic disease. betta pharma's first nda, target therapy oncology drug—icotinib, has been approved by cfda and marketed under the name of conmana© in 2011. in our pursuit to improve the lives of people, betta pharma is committed to realizing the promise of "better medicine, better life', firmly focused on our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
zhejiang beingmate technology industry & trade co., ltd
- one of the leading companies in china's baby formula market. beingmate targets at the market of nutritious food market for maternity, babies and infants from new born to twelve years old
- flagship products include baby formula, rice flour, glucose and teething biscuits
- according to some statistics, in 2009, beingmate was ranked one of the top 4 in china baby formula market and captured 9% market share
- website：
bgi tech solutions co., ltd
bgi tech provides advanced multi-omics and bioinformatics service solutions for its global customers in biomedical, agricultural, and environmental areas. bgi tech is a subsidiary company of bgi group, one of the largest genomics organizations in the world with significant contributions to genetic research and over 250 publications in top-tier journals such as nature and science. equipped with the industry's broadest array of cutting-edge technologies coupled with an experienced team of scientists and bioinformaticians, bgi tech delivers rapid, cost-effective and high-quality results that enable researchers to achieve scientific breakthroughs.
home of health ("kfzj")
- kfzj is china's largest home medical appliances and equipments retail chain, with nearly 100 stores in provinces and major cities including beijing, shanghai, tianjin, sichuan, zhejiang, jiangsu etc. kfzj is a market leader in this field in china. as a home medical appliances retail chain, it mainly sells oxygen concentrators, wheelchairs, nursing beds, inflatable bed mattresses, and blood glucose monitoring systems
- website:
china traditional chinese medicine holdings co., ltd.
- the core platform for the traditional chinese medicine segment
- china's largest manufacturer of traditional chinese medicine granules, owns two of the six cfda-approved manufacturers of traditional chinese medicine granules
- the products focus on chinese patent medicine, herbal pieces, formula granules, chemical medicine and biological medicine.
beijing jingdu children’s hospital
- children’s hospital in north beijing, prime location with rare medical service providers
- the largest child hematology and oncology center, top-ranked pediatric cardiac center, etc.
lifetech scientific co., ltd
- china’s largest player in occluders and peripheral products
- products extensively marketed in more than 90 countries through over 300 distributors
- laa closure system reaches international advanced level, blockbuster pipelines targeting rmb10 billion market; 200 people r&d team, multiple products in green channel for registration in china
raziel therapeutics
raziel therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug for the treatment of local fat reduction, developing a drug that targets obesity and related indications.
lutris pharmaceuticals
lutris pharmaceuticals develops drugs to improve anti-cancer therapy effectiveness. the company develops the topical b-raf inhibitor lut014, a proprietary small molecule that allows administration of epidermal growth factor receptor (egfr) inhibitors to patients without the interruptions caused by typical cutaneous side effects.
lutris pharma was established in 2015 and is based in tel aviv-yafo, israel.
